Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2007-05-03
Target enrollment:
Participant gender:
Summary
Prednisolone will be used as a model medication to identify new clinical outcomes for future
evaluation of new therapies in short-term studies (up to 4 weeks) in patients with Chronic
Obstructive Pulmonary Disease (COPD).